Severe Gastritis after Administration of Nivolumab and Ipilimumab

Immune checkpoint inhibitors such as ipilimumab, a cytotoxic T-lymphocyte-associated antigen-4 inhibitor, have been widely used for advanced malignancies. As these inhibitors improve antitumor immunity via T-cell modulation, immune-mediated adverse events associated with T-cell activation, such as c...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Yoshito Nishimura, Miho Yasuda, Kazuki Ocho, Masaya Iwamuro, Osamu Yamasaki, Takehiro Tanaka, Fumio Otsuka
Format:	Artigo
Sprog:	Inglês
Udgivet:	Karger Publishers 2018-08-01
Serier:	Case Reports in Oncology
Fag:	Gastritis Immune checkpoint inhibitor Ipilimumab Nivolumab Helicobacter pylori
Online adgang:	https://www.karger.com/Article/FullText/491862
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!